Safety of natalizumab reinfusion during active Sars-Cov-2 infection in patients with multiple sclerosis

被引：0
|
作者：
Landi, D. [1 ]
Cola, G. [1 ]
Mantero, V. [2 ]
Balgera, R. [2 ]
Moiola, L. [3 ]
Nozzolillo, A. [3 ]
Dattola, V. [4 ]
Sinisi, L. [5 ,6 ]
Fantozzi, R. [7 ]
Centonze, D. [7 ,8 ]
Mataluni, G. [1 ]
Nicoletti, C. G. [1 ]
Marfia, A. G. [1 ,7 ]
机构：
[1] Univ Roma Tor Vergata, Dept Syst Med, Multiple Sclerosis Clin & Res Unit, Rome, Italy
[2] ASST Lecco, MS Ctr, Lecce, Italy
[3] San Raffaele Hosp IRCCS, MS Ctr, Dept Neurol, Milan, Italy
[4] Grande Osped Metropolitano Bianchi Melacrino More, UOC Neurol, Reggio Di Calabria, Italy
[5] San Paolo Hosp ASL Napoli 1 Ctr, Neurol Unit, Naples, Italy
[6] San Paolo Hosp ASL Napoli 1 Ctr, MS Ctr, Naples, Italy
[7] IRCCS Neuromed, Neurol Unit, Pozzilli, Italy
[8] Univ Roma Tor Vergata, Dept Syst Med, Rome, Italy
来源：
MULTIPLE SCLEROSIS JOURNAL | 2021年 / 27卷 / 2_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P769
引用
收藏
页码：641 / 641
页数：1
相关论文
共 50 条
  • [1] Safety of Natalizumab infusion in multiple sclerosis patients during active SARS-CoV-2 infection
    Landi, Doriana
    Cola, Gaia
    Mantero, Vittorio
    Balgera, Roberto
    Moiola, Lucia
    Nozzolillo, Agostino
    Dattola, Vincenzo
    Sinisi, Leonardo
    Fantozzi, Roberta
    Di Lemme, Sonia
    Centonze, Diego
    Mataluni, Giorgia
    Nicoletti, Carolina Gabri
    Marfia, Girolama Alessandra
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 57
  • [2] Natalizumab administration in multiple sclerosis patients during active SARS-CoV-2 infection: a case series
    Chisari, Clara G.
    Toscano, Simona
    Arena, Sebastiano
    Finocchiaro, Chiara
    Montineri, Arturo
    Patti, Francesco
    BMC NEUROLOGY, 2021, 21 (01)
  • [3] Natalizumab administration in multiple sclerosis patients during active SARS-CoV-2 infection: a case series
    Clara G. Chisari
    Simona Toscano
    Sebastiano Arena
    Chiara Finocchiaro
    Arturo Montineri
    Francesco Patti
    BMC Neurology, 21
  • [4] SARS-CoV-2 infection and seroprevalence in patients with multiple sclerosis
    Pinar Morales, R.
    Ramirez Rivas, M. A.
    Barrero Hernandez, F. J.
    NEUROLOGIA, 2021, 36 (09): : 698 - 703
  • [5] Natalizumab safety in paediatric-onset multiple sclerosis at the time of SARS-Cov-2 pandemic
    Margoni, Monica
    Gallo, Paolo
    MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL, 2020, 6 (04)
  • [6] Humoral response to SARS-CoV-2 mRNA vaccine in patients with multiple sclerosis treated with natalizumab
    Capuano, Rocco
    Donnarumma, Giovanna
    Bisecco, Alvino
    Grimaldi, Elena
    Conte, Miriana
    d'Ambrosio, Alessandro
    Matrone, Federica
    Risi, Mario
    Borgo, Riccardo Maria
    Altieri, Manuela
    Giuliano, Federica
    Coppola, Nicola
    Galdiero, Massimiliano
    Tedeschi, Gioacchino
    Gallo, Antonio
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2021, 14
  • [7] SARS-CoV-2 Infection and Vaccination Outcomes in Multiple Sclerosis
    Brunn, Jenna A.
    Dunietz, Galit Levi
    Romeo, Andrew R.
    Braley, Tiffany J.
    NEUROLOGY-CLINICAL PRACTICE, 2022, 12 (03) : E14 - E21
  • [8] SARS-CoV-2 Infection and Risk Management in Multiple Sclerosis
    Diaz de la Fe, Amado
    Pelaez Suarez, Alejandro Armando
    Fuentes Campos, Marinet
    Cabrera Hernandez, Maivis Noemi
    Goncalves, Carlos-Alberto
    Schultz, Stephen
    Siniscalco, Dario
    Robinson-Agramonte, Maria Angeles
    DISEASES, 2021, 9 (02)
  • [9] Asymptomatic SARS-CoV-2 infection in two patients with multiple sclerosis treated with fingolimod
    Mallucci, Giulia
    Zito, Antonio
    Dal Fabbro, Beatrice
    Bergamaschi, Roberto
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 45
  • [10] The Impact of SARS-CoV-2 Infection on the Development of Neurodegeneration in Multiple Sclerosis
    Dziedzic, Angela
    Saluk-Bijak, Joanna
    Miller, Elzbieta
    Niemcewicz, Marcin
    Bijak, Michal
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (04) : 1 - 23
12345